HIV patients with moderate immune suppression at greater risk of severe COVID-19 "breakthrough" infection

People with HIV who have moderate immune suppression appear to be at greater risk of severe COVID-19 "breakthrough" infection after vaccination, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

Related Keywords

United States , American , Keri Althoff , Celeena Jefferson , Emily Henderson , Amy Justice , Lindsay Browne , Sonia Napravnik , Kathleen Akg , Brenna Hogan , Vincent Marconi , Jessie Edwards , Lily Fathi , Jacek Scarbinski , Atlantic States , Michael Silverberg , Wendy Leyden , Cameron Stewart , Sally Coburn , Eric Watson , Elizabeth Humes , Kelly Gebo , Kirsha Gordon , Michael Horburg , Carolyn Williams , Centers For Disease , Bloomberg School , Cumming School Of Medicine , National Institute Of Allergy , National Institutes Of Health , University Of North Carolina , Veterans Health Administration , Virus Epidemiology Team , Department Of Epidemiology , University Of Calgary , Johns Hopkins Bloomberg School Of Public Health , Department Of Medicine , Cohort Collaboration On Research , Johns Hopkins Bloomberg School , Study Senior Author , Associate Professor , Disease Control , Corona Infectious Virus Epidemiology Team , Kaiser Permanente Mid Atlantic States , Kaiser Permanente Northern California , Raynell Lang , Cumming School , Severe Illness After Post Vaccination , Among Adults With , Lesley Park , Deana Agil , North American , National Institute , Infectious Diseases , National Institutes , Cd4 , Fell , Covid 19 , Shiv , Flood , Epidemiology , Medicine , Public Health , Research , Vaccine ,